We are live on ! Find out more
ACM

Athyrium Capital Management Portfolio holdings

AUM $8.69M
1-Year Est. Return 34.58%
This Fund
S&P 500
This Quarter Est. Return
+16.8%
1 Year Est. Return
-34.58%
3 Year Est. Return
-25.1%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$267M
AUM Growth
+$29.3M
Cap. Flow
-$108M
Cap. Flow %
-40.57%
Top 10 Hldgs %
98.66%
Holding
11
New
–
Increased
1
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
RVLP
RVL Pharmaceuticals plc Ordinary Shares
RVLP
+$12.5M

Top Sells

Rank Stock Value
1
CMAX
CareMax, Inc. Class A Common Stock
CMAX
+$135K

Sector Composition

Rank Sector Weight
1 Healthcare 54.66%
2 Miscellaneous 45.34%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMYT
1
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$61.3M 22.96%
8,857,268
– –
CMAX
2
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
$31.7M 11.86%
148,907
-667
-0.4% -$135K
RVLP
3
DELISTED
RVL Pharmaceuticals plc Ordinary Shares
RVLP
$30.7M 11.48%
14,600,444
+6,451,612
+79% +$12.5M
BIOR
4
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
$14.5M 5.42%
119,423
– –
PBYI icon
5
Puma Biotechnology
PBYI
$472M
$4.25M 1.59%
1,792,114
– –
SCTL
6
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$3.59M 1.34%
2,202,420
– –

Similar funds

BGC
Birch Grove Capital New York $9.51M AUM 0.22% 1-Year Est. Return
RVM
RiverVest Venture Management St. Louis, Missouri $6.84M AUM 7.71% 1-Year Est. Return
JDR
Jay D. Rosenbaum $6.69M AUM 4.68% 1-Year Est. Return
DA
DSC Advisors Chicago, Illinois $11M AUM 5.88% 1-Year Est. Return
KIM
Kaizen Investment Management Singapore $6.23M AUM
RJTCONH
Raymond James Trust Company of New Hampshire Portsmouth, New Hampshire $12.1M AUM 28.84% 1-Year Est. Return
HSC
Harbor Spring Capital New York $12.3M AUM
HVM
Harvest Volatility Management Norwalk, Connecticut $4.39M AUM 13.08% 1-Year Est. Return

Athyrium Capital Management's Q3 2022 Portfolio in Review

As of Q3 2022, Athyrium Capital Management held 11 positions worth $267M, up 12% from $238M the previous quarter. Its ten largest holdings account for 99% of the portfolio.

Athyrium Capital Management withdrew a net $108M in Q3 2022, closing 1 position and reducing 1 holding. Its largest reduction was CareMax, Inc. Class A Common Stock, cutting an estimated $135K.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, up from 49% a quarter earlier, followed by Miscellaneous.

Against the trend, Athyrium Capital Management added an estimated $12.5M to RVL Pharmaceuticals plc Ordinary Shares.

  • Athyrium Capital Management added most to RVL Pharmaceuticals plc Ordinary Shares in Q3 2022, an estimated $12.5M increase.
  • Athyrium Capital Management's biggest Q3 2022 reduction was CareMax, Inc. Class A Common Stock, cutting an estimated $135K.
  • Athyrium Capital Management's ten largest holdings make up 99% of its $267M portfolio in Q3 2022.
  • Athyrium Capital Management opened 0 new positions and closed 1 in Q3 2022.
  • Athyrium Capital Management's portfolio value rose 12% quarter-over-quarter to $267M.

Based on Athyrium Capital Management's 13F filing for Q3 2022, filed 14 Nov 2022.